Yoshiki Yui-Iwanaga

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Erratum: Author Correction: Concerns on a new therapy for severe heart failure using cell sheets with skeletal muscle or myocardial cells from iPS cells in Japan.

Erratum: Author Correction: Concerns on a new therapy for severe heart failure using cell sheets with skeletal muscle or myocardial cells from iPS cells in Japan.

Journal: NPJ Regenerative medicine

Published: July 14, 2018

Concerns on a new therapy for severe heart failure using cell sheets with skeletal muscle or myocardial cells from iPS cells in Japan.

Concerns on a new therapy for severe heart failure using cell sheets with skeletal muscle or myocardial cells from iPS cells in Japan.

Journal: NPJ Regenerative medicine

Published: November 20, 2017

Questions Surrounding iPS Cells in Japan.

Questions Surrounding iPS Cells in Japan.

Journal: International journal of stem cells

Published: April 21, 2016

Prevention of misconduct in clinical trials in Japan.

Prevention of misconduct in clinical trials in Japan.

Journal: Lancet (London, England)

Published: September 23, 2014

Estimated glomerular filtration rate reversal by blood pressure lowering in chronic kidney disease: Japan Multicenter Investigation for Cardiovascular DiseaseB CKD study.

Estimated glomerular filtration rate reversal by blood pressure lowering in chronic kidney disease: Japan Multicenter Investigation for Cardiovascular DiseaseB CKD study.

Journal: Journal of clinical hypertension (Greenwich, Conn.)

Published: March 06, 2013

Concerns about the Jikei Heart Study.

Concerns about the Jikei Heart Study.

Journal: Lancet (London, England)

Published: April 17, 2012

Reverse remodeling and improved function by antihypertensive treatment in hypertensive patients with coronary artery disease.

Reverse remodeling and improved function by antihypertensive treatment in hypertensive patients with coronary artery disease.

Journal: Journal of hypertension

Published: November 21, 2009

Nifedipine retard prevents hospitalization for angina pectoris better than angiotensin-converting enzyme inhibitors in hypertensive Japanese patients with previous myocardial infarction (JMIC-B substudy).

Nifedipine retard prevents hospitalization for angina pectoris better than angiotensin-converting enzyme inhibitors in hypertensive Japanese patients with previous myocardial infarction (JMIC-B substudy).

Journal: Journal of hypertension

Published: September 22, 2007

Unstable angina and non-ST elevation acute coronary syndrome: epidemiology and current management in Japan (Japan Multicenter Investigation for Cardiovascular Disease-D (JMIC-D) Committee).

Unstable angina and non-ST elevation acute coronary syndrome: epidemiology and current management in Japan (Japan Multicenter Investigation for Cardiovascular Disease-D (JMIC-D) Committee).

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: August 28, 2007

Nifedipine retard was as effective as angiotensin converting enzyme inhibitors in preventing cardiac events in high-risk hypertensive patients with diabetes and coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) subgroup analysis.

Nifedipine retard was as effective as angiotensin converting enzyme inhibitors in preventing cardiac events in high-risk hypertensive patients with diabetes and coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) subgroup analysis.

Journal: Hypertension research : official journal of the Japanese Society of Hypertension

Published: August 11, 2004

Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial.

Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial.

Journal: Hypertension research : official journal of the Japanese Society of Hypertension

Published: April 15, 2004

Showing 1-11 of 11

Last Updated: 09/26/2026